Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices Study - Scorecard - MDSpire

Real-World Insights on Disease Management and Treatment Approaches for Chronic Spontaneous Urticaria in Chinese Patients: Findings from the Urticaria Voices Study

  • By

  • Zuotao Zhao

  • Yi Li

  • Tara Raftery

  • Nadine Chapman-Rothe

  • Pallavi Saraswat

  • Jessica McCarthy

  • Ravneet Kaur Kohli

  • Cristina Constantinescu

  • Angie Li

  • Guojiao You

  • Ruixin Tan

  • Bin Yang

  • July 15, 2026

Share

Clinical Scorecard: Real-World Insights on Disease Management and Treatment Approaches for Chronic Spontaneous Urticaria in Chinese Patients: Findings from the Urticaria Voices Study

At a Glance

CategoryDetail
ConditionChronic Spontaneous Urticaria (CSU)
Key MechanismsRecurring itchy wheals and/or angioedema lasting more than 6 weeks without identifiable external triggers.
Target PopulationPatients with CSU in China, approximately 18 million affected.
Care SettingRoutine clinical practice in China.

Key Highlights

  • 35% of treated patients report inadequate disease control (UCT < 12).
  • 84% of patients consider complete symptom control highly important, but only 16% find it achievable.
  • Traditional Chinese Medicine is used by 38% of patients alongside conventional treatments.
  • Only 7% of patients recommended advanced therapies actually utilize them.
  • 51% of patients escalating antihistamine doses experience new side effects.

Guideline-Based Recommendations

Diagnosis

  • Self-reported physician-confirmed diagnosis of CSU.

Management

  • Second-generation H1-antihistamines as first-line therapy, with dose escalation if necessary, followed by biologic treatment and ciclosporin.

Monitoring & Follow-up

  • Assessment of disease control through Urticaria Control Test (UCT).

Risks

  • Potential side effects from antihistamine dose escalation, including drowsiness.

Patient & Prescribing Data

Patients with CSU in China, aged 18 and older.

Patients actively seek complementary therapies, with significant barriers to accessing effective treatments.

Clinical Best Practices

  • Implement structured follow-up schedules to improve disease management.
  • Enhance treatment access and affordability to align with patient needs.
  • Consider patient-reported outcomes in treatment planning.

Related Resources & Content

Original Source(s)

Related Content